-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The COVID-19 pandemic has become the biggest and most serious public health problem for generations, but there is still no optimal treatment plan.
COVID-19 Vitamin D
Researchers randomly recruited COVID-19 inpatients from three hospitals in the UK and collected their data retrospectively.
As a result, a total of 986 COVID-19 patients were included in the study, of which 151 (16.
In summary, in this observational study, regardless of the patient's baseline serum 25(OH)D level, intensive treatment with cholecalciferol seems to reduce the risk of death in acute hospitalized patients with COVID-19.
Original source:
Stephanie F Ling, et al.
ncbi.
nlm.
nih.
gov/33322317/" target="_blank" rel="noopener">High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study in this message